版本:
中国

BRIEF-Protalix Biotherapeutics says presentation of clinical trial results for alidornase alfa

May 23 Protalix Biotherapeutics Inc

* Protalix Biotherapeutics announces presentation of Phase II clinical trial results for Alidornase Alfa in cystic fibrosis at the 40th European cystic fibrosis society conference Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐